{
    "2018-07-20": [
        [
            {
                "time": "2018-07-21",
                "original_text": "基金仓位大幅下降 成长板块超比例仍低",
                "features": {
                    "keywords": [
                        "基金仓位",
                        "成长板块",
                        "超配比例"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "恒瑞医药关于获得药物上市许可的公告",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "药物上市",
                        "许可"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "华联综超关于转让控股子公司股权的关联交易公告",
                "features": {
                    "keywords": [
                        "华联综超",
                        "股权转让",
                        "关联交易"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "恒瑞医药需重新估值 创新药子板块将上演“戴维斯双击”——专访雷球资产投资总监顾斌",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "重新估值",
                        "创新药",
                        "戴维斯双击"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "恒瑞医药：替格瑞洛缓释胶囊获得药物临床试验批件",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "替格瑞洛",
                        "临床试验"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "恒瑞医药：11名高管拟合计减持不超过234.91万股",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "高管减持",
                        "股份计划"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "医药行业黑天鹅频出 估值偏高下医药股还具投资价值?",
                "features": {
                    "keywords": [
                        "医药行业",
                        "黑天鹅",
                        "估值偏高"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "逾1400家公司中期业绩预喜 周期行业亮点纷呈",
                "features": {
                    "keywords": [
                        "中期业绩",
                        "预喜",
                        "周期行业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "周期行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}